Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Launches Lung Cancer Diagnostic

Premium

Rosetta Genomics this week launched miRview Lung, its microRNA-based diagnostic designed to differentiate neuroendocrine tumors from non-small cell lung tumors, and then subtype neuroendocrine tumors into small cell lung cancer and carcinoid, and non-small cell lung tumors into squamous and non-squamous.

The test will be commercialized in the US by the company's recently formed sales team (GSN 5/5/2011). International sales will be handled by Rosetta's various distribution partners.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.